TOXYLACT: a02 introduction

The first professional lActological database in the word

ATC A02 – Drugs for Acid Related Disorders

Drugs in the ATC A02 group belong to the anatomical main group “Alimentary tract and metabolism” and are used in the prevention and treatment of acid related disorders in the upper gastrointestinal tract. They include medicines that neutralise gastric acid, reduce its secretion or protect the mucosa in conditions such as dyspepsia, peptic ulcer disease and gastro‑oesophageal reflux disease (GORD).

A02A – Antacids

Antacids are medicines that neutralise existing gastric acid and provide rapid, short‑term relief of symptoms like heartburn and acid indigestion. This subgroup includes simple magnesium, aluminium or calcium compounds, as well as fixed combinations with antiflatulents, antispasmodics or other ingredients designed to improve symptom control.

A02B – Drugs for peptic ulcer and GORD

A02B comprises drugs that primarily act by reducing gastric acid secretion or enhancing mucosal protection in peptic ulcer disease and gastro‑oesophageal reflux disease. It includes H2‑receptor antagonists, proton pump inhibitors, prostaglandin analogues, combinations for eradication of Helicobacter pylori, and other agents used for long‑term management and prevention of ulcer complications and reflux symptoms.

A02X – Other drugs for acid related disorders

The A02X subgroup covers drugs for acid related disorders that do not fit into the antacid or peptic‑ulcer/GORD subgroups. These preparations may have specific or mixed mechanisms of action and are classified here when they cannot be assigned to A02A or A02B based on their main therapeutic use.

Short illustration example

For example, a simple magnesium hydroxide antacid is coded in A02A, whereas omeprazole, a proton pump inhibitor for reflux and ulcers, is coded A02B, and certain less common protective agents are classified in A02X. This structure helps clinicians, researchers and regulators group medicines consistently according to their main use in acid related gastrointestinal disorders.

Recent Posts

July 24

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

July 18

Abdominal Compartment Syndrome

While the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 14

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

Spotlight


A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.